Premium
SECOND CANCER INCIDENCE IN CLL PATIENTS RECEIVING BTK INHIBITORS
Author(s) -
Bond D.A.,
Huang Y.,
Fisher J.,
Ruppert A.,
Owen D.,
Bertino E.,
Rogers K.,
Bhat S.,
Jaglowski S.,
Grever M.,
Byrd J.,
Maddocks K.,
Woyach J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.51_2631
Subject(s) - chronic lymphocytic leukemia , medicine , ibrutinib , population , incidence (geometry) , cumulative incidence , confidence interval , cancer , oncology , poisson regression , leukemia , cohort , physics , environmental health , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom